hepatitis C

This Was, Unquestionably, the Most Disappointing Drug Launch of 2016
Motley Fool
Tue, 01/31/17 - 09:51 am
drug launches
Merck
Zepatier
hepatitis C
Regulus hits further setbacks as clinical hold upheld
BioPharma Dive
Mon, 01/30/17 - 11:40 am
Regulus
clinical trials
RG-101
hepatitis C
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Mon, 01/23/17 - 10:26 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Zepatier Should Boost Merck’s Profit Margins in the Future
Market Realist
Mon, 01/2/17 - 12:00 pm
Merck
Zepatier
hepatitis C
This Army Vet Is Fighting Hep C With Big Pharma’s Help
Bloomberg
Thu, 12/29/16 - 10:18 am
hepatitis C
AbbVie
Merck
Gilead Sciences
BMY’s Hepatitis C Franchise May See a Drop in Revenues in 2016
Market Realist
Thu, 12/22/16 - 10:26 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
AbbVie Files for Approval of Hepatitis C Treatment in the US
Yahoo/GuruFocus
Tue, 12/20/16 - 12:20 pm
AbbVie
hepatitis C
glecaprevir/pibrentasvir
Gilead’s Patent Loss to Merck Started With a Broken Friendship
Bloomberg
Mon, 12/19/16 - 10:55 am
Gilead Sciences
Merck
patents
hepatitis C
Sovaldi
Harvoni
Merck Wins Record $2.5 Billion Patent Verdict Against Gilead
Bloomberg
Fri, 12/16/16 - 09:51 am
Merck
patents
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead Sciences Inc.'s Best Moves in 2016
Motley Fool
Thu, 12/15/16 - 12:00 pm
Gilead Sciences
NASH
hepatitis C
filgotinib
Galapagos
Gilead's HCV NDA Means Nothing
Seeking Alpha
Sun, 12/11/16 - 11:55 am
Gilead Sciences
hepatitis C
SOF/VEL/VOX
Epclusa
AbbVie
Gilead Sciences Inc.'s Worst Moves in 2016
Motley Fool
Tue, 12/6/16 - 10:44 pm
Gilead Sciences
dividends
hepatitis C
M&A
Gilead Sciences' HCV Fall Was Partially Offset by HIV Business
Market Realist
Mon, 11/28/16 - 11:26 pm
Gilead Sciences
hepatitis C
HIV
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
hepatitis C
Gilead Sciences
AbbVie
Epclusa
glecaprevir/pibrentasvir
sofosbuvir/velpatasvir
AbbVie's pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
Fierce Pharma
Tue, 11/15/16 - 09:36 am
AbbVie
hepatitis C
Gilead Sciences
Epclusa
Gilead hepatitis C pill was biggest 2015 drug cost for Medicare, Medicaid
Stat/Pharmalot
Tue, 11/15/16 - 09:24 am
Gilead Sciences
hepatitis C
Medicare
Medicaid
Harvoni
Merck Reports Triple-Combo Results
https://yhoo.it/2fT1k83
Mon, 11/14/16 - 10:38 pm
Merck
hepatitis C
AbbVie reports positive 8-week data in HCV
BioPharma Dive
Mon, 11/14/16 - 12:00 pm
AbbVie
hepatitis C
glecaprevir/pibrentasvir
Gilead's Q3 Bombshell: No More Hepatitis C R&D
Motley Fool
Thu, 11/3/16 - 09:33 am
Gilead Sciences
R&D
hepatitis C
Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner
Motley Fool
Sat, 10/29/16 - 01:19 pm
FDA
Gilead Sciences
hepatitis C
Harvoni
Sovaldi

Pages